Vivo Opportunity, Llc - Net Worth and Insider Trading

Vivo Opportunity, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Vivo Opportunity, Llc owns 8 companies in total, including ALX Oncology Holdings Inc (ALXO) , Crinetics Pharmaceuticals Inc (CRNX) , and Sierra Oncology Inc (SRRA) among others .

Click here to see the complete history of Vivo Opportunity, Llc’s form 4 insider trades.

Insider Ownership Summary of Vivo Opportunity, Llc

Ticker Comapny Transaction Date Type of Owner
ALXO ALX Oncology Holdings Inc 2020-07-21 10 percent owner
CRNX Crinetics Pharmaceuticals Inc 2020-01-29 10 percent owner
SRRA Sierra Oncology Inc 2019-11-22 10 percent owner
KDMN Kadmon Holdings Inc 2019-01-07 10 percent owner
BOLT Bolt Biotherapeutics Inc 2021-02-09 10 percent owner
TERN Terns Pharmaceuticals Inc 2022-08-12 10 percent owner
SLNO Soleno Therapeutics Inc 2023-10-02 10 percent owner
IOBT IO Biotech Inc 2023-08-09 10 percent owner

Vivo Opportunity, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Vivo Opportunity, Llc Ownership Network

Ownership Network List of Vivo Opportunity, Llc

No Data

Ownership Network Relation of Vivo Opportunity, Llc


Vivo Opportunity, Llc Owned Company Details

What does ALX Oncology Holdings Inc do?

Who are the key executives at ALX Oncology Holdings Inc?

Vivo Opportunity, Llc is the 10 percent owner of ALX Oncology Holdings Inc. Other key executives at ALX Oncology Holdings Inc include director & President and CEO Jaume Pons , director & 10 percent owner Jason Lettmann , and VP & Finance and CAO Shelly Pinto .

ALX Oncology Holdings Inc (ALXO) Insider Trades Summary

Over the past 18 months, Vivo Opportunity, Llc made no insider transaction in ALX Oncology Holdings Inc (ALXO). Other recent insider transactions involving ALX Oncology Holdings Inc (ALXO) include a net sale of 73,208 shares made by Jaume Pons , a net sale of 10,528 shares made by Shelly Pinto , and a net purchase of 4,400 shares made by Jason Lettmann .

In summary, during the past 3 months, insiders sold 70,000 shares of ALX Oncology Holdings Inc (ALXO) in total and bought 4,400 shares, with a net sale of 65,600 shares. During the past 18 months, 86,228 shares of ALX Oncology Holdings Inc (ALXO) were sold and 4,400 shares were bought by its insiders, resulting in a net sale of 81,828 shares.

ALX Oncology Holdings Inc (ALXO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ALX Oncology Holdings Inc Insider Transactions

No Available Data

Vivo Opportunity, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Vivo Opportunity, Llc. You might contact Vivo Opportunity, Llc via mailing address: 192 Lytton Avenue, Palo Alto Ca 94301.

Discussions on Vivo Opportunity, Llc

No discussions yet.